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Abstract 
Total hip arthroplasty (THA) is highly successful for reducing pain and improving function, providing health 
related quality of life benefit.  Demand for THA is increasing with associated increase in revision hip surgery. 
Hip arthroplasty surveillance (long term follow up) can identify asymptomatically failing THA to prepare for 
revision surgery, reducing potential for complications or complexity of surgery.  But, it is unknown whether the 
surveillance of THA can be shown to improve the patient outcomes or reduce costs around revision surgery. 
With the current need to reduce unnecessary health consultations and to show the economic advantages of 
any service, the purpose of this study is to consider the relative effectiveness of hip arthroplasty surveillance on 
revision hip arthroplasty. 
This is a single centre, observational study in which consecutive patients undergoing aseptic revision of THA 
over twelve months in a large orthopaedic unit will be considered for participation.  Primary outcome 
measures will be change in each of three valid patient reported scores from pre-operatively to 12 months post-
surgery. Secondary outcomes will be the costs of treatment calculated using data obtained from the 
participants’ hospital records and a self-report questionnaire 
An exploratory approach will be used to investigate the effect of surveillance on the outcomes of interest.  A 
linear mixed method model will be used to study the change in scores between baseline and 12months.   The 
economic evaluation will be a cost-utility analysis, which compares the value of alternative interventions by 
attaching costs to the quality adjusted life years produced by each intervention.  
 
Introduction 
Total hip arthroplasty has been shown to be a surgical procedure which decreases pain and improves function 
for the patient, and has significant health related quality of life benefit when compared with other procedures 
(Patel, Pavlou et al. 2015).  The National Joint Registry for England, Wales and Northern Ireland shows a steady 
increase in the number of procedures undertaken each year (National Joint Registry 2016).  Revision of a hip 
replacement is necessary when the primary arthroplasty fails, which can be for one of a number of reasons.  
Early failure of a joint replacement may be the result of infection in the joint (septic) or an aseptic cause such as 
dislocation, component failure or adverse response of the host body to the implanted material, particularly in 
metal on metal articulations. These conditions will be accompanied by symptoms that will prompt the patient 
to seek medical help. Mid-term and late failure occur five years or more from the primary surgery and may be 
due to late infection, which will be accompanied by symptoms, but more often are aseptic in nature and 
asymptomatic until the later stages.  The causes include debonding of the components from the host bone with 
subsequent instability, or wear of the components with production of wear debris. This wear debris can disrupt 
bone metabolism leading to destruction of bone around the hip replacement (osteolysis), predisposing the 
patient to periprosthetic fracture (Harris 2004, Katz, Wright et al. 2014).   
As the demand for hip arthroplasty increases due to presentation of patients at a younger age, increased life 
expectancy and a prevalence of obesity, the burden of revision is predicted to rise 31% by 2030 (Patel, Pavlou 
et al. 2015). This is associated with significant costs as revision surgery is more expensive to the health service 
than a primary procedure, the cost being determined by the indication for the surgery.  In 2014, 4% of revision 
hip surgeries in England, Wales and Northern Ireland were undertaken for infection and 57% for aseptic 
loosening or lysis (National Joint Registry 2016).  Vanhegan et al (2012) calculated that the average cost of 
revision for infection was £21,937, for peri-prosthetic fracture was £18,185 and for aseptic loosening was 
£11,897 (Vanhegan, Malik et al. 2012).   Although peri-prosthetic fracture can be classified as an aseptic 
revision, the cost of revision for peri-prosthetic fracture is one third higher than for aseptic loosening without 
fracture due to the technical demands, the additional components required and the associated high rate of 
complications which may affect recovery (da Assunção, Pollard et al. 2015).   
The advantage of hip arthroplasty surveillance (long term follow up) is that it provides screening by specialists 
who can identify failing joints. Failure of hip replacements due to wear and loosening is radiologically evident 
but often asymptomatic, meaning that the patient is unaware of change until significant bone loss has 
occurred.  Routine surveillance offers the opportunity to identify asymptomatically failing hip replacements 
and plan for revision surgery, thus reducing the potential for peri-prosthetic fracture or other complications.   
In addition to any cost saving at the time of surgery, this is thought to benefit the patient and the orthopaedic 
surgeon, who would otherwise be faced with a more complex reconstructive process and rehabilitation 
(Howard 2009). 
Long term follow up of hip arthroplasty is recommended by many in the orthopaedic community in order to 
monitor in vivo responses and to identify failure (British Orthopaedic Association, British Hip Society et al. 
2014, Hart, Sabah et al. 2015). Current guidelines include the use of the ODEP rating, which is a measure of the 
revision rating of a component based on data supplied by the manufacturing company (Orthopaedic Data 
Evaluation Panel 2015).  There is a letter and a number, the former denoting the strength of the evidence and 
the latter the number of years to which it relates. For instance, an acetabular cup with an ODEP 10A rating 
means that evidence exists that at least 90% of that specific component are still in situ (in the patient) at 10 
years.  For a component with an ODEP rating of 10A, it is recommended that a follow up is offered by the 
orthopaedic team at one year, seven years and three yearly thereafter, with review of x-ray images by a health 
professional with the required specialist knowledge.  For a component that has not achieved the 10A rating, it 
is recommended that there is annual follow up for the first five years, then two yearly up to ten years and three 
yearly thereafter (British Orthopaedic Association, British Hip Society et al. 2014).    
The interpretation of the guidelines for follow up does, however, have some complications.  A hip replacement 
incorporates both an acetabular and a femoral component, and each is rated independently. The latest report 
from the National Joint Registry for England, Wales and Northern Ireland shows that, of the components used 
in 2014, 89% of cemented femoral stems, 69% of cementless femoral stems and 43% of acetabular cups had a 
10A rating.  But, the same report shows that, in 13% of hip replacements, the surgeon had used a femoral 
component from one manufacturer and an acetabular component from another manufacturer, known as ‘mix 
and match’ (National Joint Registry 2016).  Finally, the results of a recent survey suggest that there is a variety 
of follow up practice across the UK with only 43% of orthopaedic units offering any form of follow up five years 
after primary surgery (Smith 2014).   
In the present economic climate, there is a need to reduce unnecessary health consultations and a growing 
requirement to show the economic advantage of any service that is provided in order to develop a ‘leaner’ 
health care system (Corbacho 2015, Fillingham 2008).  Many members of the orthopaedic community consider 
that some follow up is of value for hip arthroplasty patients although this is threatened by lack of funding.  
However, it is still unknown whether or not routine surveillance of this group of patients has any benefit 
through improving the patient outcomes at the time of revision surgery or through reduction of the associated 
costs.  The purpose of this study is to consider the relative effectiveness of hip arthroplasty surveillance: Does 
revision with surveillance have a different outcome to revision without surveillance? 
Objectives 
The primary objective is to investigate if there is a difference in the health related quality of life after hip 
revision surgery between patients diagnosed through routine surveillance and those who have not had any 
form of long term follow up. 
The secondary objective is to determine if there is a difference in the costs of revision hip surgery and early 
postoperative care between patients diagnosed through routine surveillance and those who have not had any 
form of long term follow up. 
Materials and methods 
Study design and duration 
This study is a designed to inform a larger study at a later date and will take place at a single centre.  It will be 
an observational study over a twelve month period to compare the relative effectiveness of surveillance or lack 
of surveillance on revision hip arthroplasty.   
Participants 
The criteria that will be applied to the selection of possible participants are shown in Table 1. 
Table 1.  Criteria for selection of study participants 
Inclusion Exclusion 
• Adults listed for revision of a primary hip 
arthroplasty 
• Revision of acetabular or femoral or both 
components of a hip arthroplasty 
• Less than five years from primary operation 
• Revision for infection of the hip arthroplasty 
• Unable to complete postal questionnaires e.g. 
dementia 
 
Comparators 
Revision with surveillance 
For the purposes of this study, hip arthroplasty surveillance will be considered as planned orthopaedic review 
of the hip implant that now requires revision surgery.  The review(s) will have taken place at any time in the 
period that commences five years after the primary operation and continues to the present day, and will 
include an x-ray image of the affected hip.  As there are currently a variety of review intervals in use, all 
intervals will be included (Smith 2014).  The patients in this group will be considered as those with surveillance. 
Revision without surveillance 
The comparator group will be those patients who are scheduled for revision surgery following an emergency 
admission, or following a GP referral for problems with the hip implant.  They will be considered to be those 
with no orthopaedic long term follow up of their hip arthroplasty and, therefore, without surveillance. 
In some units, patients are selected for review based on their type of implant or associated research funding.  It 
is beyond the scope of this study to consider sub groups of selective follow up, and a pragmatic approach will 
be adopted of surveillance versus no surveillance. 
Recruitment 
Patients will be recruited to this study by one of two routes (see Figure 1).  The first is for those whose revision 
hip surgery is planned in advance.  The date of surgery will be obtained from Southmead Hospital 
approximately one month in advance of the date of operation, and the medical record will be screened for 
inclusion criteria by the principal investigator.  Any patient that is deemed to be eligible will subsequently be 
sent an invitation letter and information leaflet to read at home.  When they attend the pre-operative 
assessment clinic, they will be asked about participation in the study by a designated, named research nurse.  If 
they consent to participate, they will be given the first questionnaire at that time and asked to complete and 
return it prior to their surgery using the pre-paid envelope which will be supplied.   
The second route of recruitment is for those patients who are in hospital and awaiting revision hip surgery 
following an emergency admission.  The names of prospective participants will be obtained by the designated 
research nurse through liaison with co-researchers who are present in the daily trauma meeting, and she/he 
will review the medical records (present on the ward) for eligibility.  No information will be extracted or 
recorded if the patient is ineligible.  She/he will visit any eligible patient on the ward to describe the study and 
to leave an information leaflet with the patient.  She/he will return at a pre-agreed time to take consent if the 
patient is willing and able to participate.  The pre-operative questionnaire will be completed by the patient any 
time preceding their surgery, either in paper form with return by pre-paid envelope or by the research nurse 
recording their verbal responses to the questionnaire.  The patient will be offered this option to minimise the 
burden of participation while awaiting surgery.  
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Figure 1. Participant flow through Whistl:er study 
Key: OHS = Oxford Hip Score, EQ-5D = EuroQol 5D-5L health questionnaire, UCLA = University of Southern California at Los 
Angeles activity score 
Assignment 
The assignment of each patient to one of the two groups will be retrospective, twelve months after their 
revision hip surgery, and will be based on their medical records.  Any uncertainty will be clarified directly with 
the patient by the principal investigator. 
Intervention 
The intervention will consist of questionnaires administered at three time points.  The first will be a pre-
operative questionnaire; the second will be a health resource use questionnaire at six months post-
operatively; the final questionnaire, a repeat of the first questionnaire, will be at 12 months post-operatively.   
At the time of completion of the pre-operative questionnaire, details of the participant’s name, age, diagnosis 
and comorbidities will be collected and stored electronically in a spreadsheet within a hospital trust electronic 
clinical folder.  Each participant will be allocated a unique number which will be used for further data 
collection.  Questionnaire response will be recorded against the unique number of each participant on an 
encrypted laptop computer.  No patient identifiable information will leave the hospital site at any time.  If any 
questionnaire is not returned by a participant, a reminder letter will be issued two weeks after the anticipated 
return date of the questionnaire.  If there is still no response, an attempt will be made to telephone the 
patient to request the return of the questionnaire.  
The final data will be collected from participant’s medical records 12 months after the revision hip surgery and 
will take place on hospital premises.  These details include the surgical procedure, any additional in-patient 
costs, length of stay and out-patient visits before and after the revision surgery.   The medical records will be 
retrieved by an NHS administrator and reviewed by the primary researcher or research nurse.  The unique 
identifier of each participant will be used to record the data on an encrypted computer. 
Concomitant care 
The medical care of the patient will be unaffected by this study which is purely observational. 
Study outcomes 
Primary outcome measures 
Primary outcome measures will be the change on each of three valid scores, measuring pain and function, 
activity and quality of life, from pre-operatively to 12 months post-surgery.  
The Oxford Hip Score (OHS) is a widely used score consisting of twelve questions (score range from zero which 
is poor to 48, best outcome) and has been shown to be valid and reliable for use in revision hip surgery 
(Dawson, Fitzpatrick et al. 2001).  Pain and function (six questions for each) will be analysed separately as it 
has been shown to be reliable when used in this way and it has been suggested that pain may be more 
sensitive to change than other measures in the two years following revision hip arthroplasty (Harris, Price et al. 
2014, Zampelis, Ornstein et al. 2014).   
The EuroQol-5D (EQ-5D-5L) is a widely used score of general health consisting of five questions with five levels 
each and a visual analogue scale to record health state (EuroQol Group 2010).  It can be used to calculate the 
quality adjusted life years for a given condition and is widely used with hip arthroplasty as part of the PROMS 
programme from the Health and Social Care Information centre (Health and Social Care Information Centre 
2013).  The five level score is converted to a value between -1.0 to 1.0 where zero represents a state 
equivalent to death and 1.0 equates to perfect health.  There is a reference set of data for a UK population 
which is useful for interpretation of results and calculation of cost.   
The University of Southern California at Los Angeles (UCLA) activity score will be used to measure the change 
in activity level of each patient.  It has been shown to be a simple and reliable measure to use at the time of 
hip arthroplasty and is freely available for use (Naal, Impellizzeri et al. 2009).  It consists of ten levels of activity 
described in words and the patient selects one level to best describe their current state (range from one to 10 
with a high value representing a more active lifestyle). 
In order to avoid undue patient burden, these questionnaires will not be repeated six months post-surgery as 
the patient will be asked to complete postal versions of two of them (OHS and EQ-5D-3L) at that time for the 
national PROMS programme.  Our preparatory work with patients and the public has highlighted that a repeat 
of these questionnaires for study purposes at six months often causes confusion and patient overload.    
Permission to use each of the scores was obtained from the appropriate organisation, prior to commencement 
of the study. 
Secondary outcome measures 
The secondary outcome measure will be the costs of treatment, as shown in Table 2.  The health costs will be 
calculated using data obtained from the participants’ hospital records and from a self-report questionnaire.  
The participants will each be given a log book to keep a record of their use of resources over the six months 
after discharge from hospital.  A questionnaire will then be sent to their home for completion using the log 
book at six months after surgery.  The self-report questionnaire will also be used to collect data that indicate 
any personal costs (non-prescribed medication and time off work). 
Table 2. Cost data to be collected 
Costs 
 
Duration Data  source 
Initial operation including 
prostheses, length of stay, 
additional procedures, return to 
theatre 
 
Time zero to 12 months post-
surgery 
Hospital records of patient 
Inpatient care post-discharge Time zero to 12 months post-
surgery 
Hospital records of patient 
Outpatient care Time zero to 12 months post-
surgery 
Hospital records of patient 
Primary/community care 
 
Time zero to 6 months post-op Self-report questionnaire 
Medications 
 
Time zero to 6 months post-op Self-report questionnaire 
Aids/Adaptations 
 
Time zero to 6 months post-op Self-report questionnaire 
 
The self-report data will only be collected for six months for two reasons: a) it is the time period in which there 
will be the greatest effect on the participant’s lifestyle, and b) compliance with completion of self-report data 
will be improved by limiting the time period and reducing the patient burden. 
Statistical analysis 
This is an observational study and we intend to use an exploratory approach to investigate the effect of 
surveillance or lack of surveillance on the outcomes of interest.   
Primary outcomes 
The study of the change in patient reported outcome scores between baseline and 12 months assessment will 
be performed with a linear mixed method model to account for repeated measurements within patients.  For 
each outcome score, the main analysis will regress the baseline and 12 month assessment on long term follow 
up status, the indicator of assessment time (zero or 12 months) and their interaction.  The confidence intervals 
and p-value related to this interaction will provide the quantitative findings to determine if there is a 
difference in the change of recovery between participants with and without surveillance.  The analyses will be 
adjusted for potential confounders including the type of hip replacement. 
Depending on the size of the study sample, we will investigate further the impact of both observed and 
unobserved confounders using a matching technique such as a propensity score method. 
Secondary outcomes 
The economic evaluation of health benefits will be performed with a cost-utility analysis, which compares the 
value of alternative interventions by attaching costs to the quality adjusted life years (QALY) produced by each 
intervention (costs/QALYs) (McCabe 2009).  A ratio is then constructed from the differences in costs and QALYs 
of each of the interventions, the incremental cost-effectiveness ratio (ICER).  This can be compared with a 
threshold ICER for the NHS to indicate the likelihood of funding the intervention and has been applied in a 
similar research study comparing the cost-effectiveness of resurfacing arthroplasty with total hip replacement 
(Edlin, Tubeuf et al. 2012).  Although this technique is known to have some disadvantages, such as the inability 
to capture the patient experience, the results will be considered in conjunction with planned simultaneous 
qualitative research study. 
Sample size 
This is an observational pilot study and all eligible patients will be included.  The group allocation will be 
retrospective, determined from medical records and patient corroboration. No sample size will be determined 
in advance as it is unknown what proportion of patients will be eligible and available for each group although 
existing local data suggests that approximately 180 patients may be eligible in a twelve month period. 
Organisation 
Monitoring 
This study forms one part of a research plan in the NIHR five year clinical lectureship awarded to the primary 
researcher.  It will be sponsored by the hosting NHS Trust and monitored with reference to the team of experts 
already in existence for the duration of the research fellowship. Data monitoring will be conducted through bi-
monthly meetings between the statistician and the primary researcher, with reference to two of the 
professors with expertise in this area (health economics and musculoskeletal rehabilitation).  In addition, the 
two patient partners will continue to be invited to comment on all aspects of the study.  Due to the combined 
expertise available from this group, no additional data monitoring committee will be required for this single-
centre observational study.   
No harm will be caused from participation in this study but withdrawal for any reason, including participant 
burden, will be recorded, summarised and presented with the results. 
Ethics 
Research ethics approval for this study was granted from the NHS Health Research Authority (London - 
Camden and King’s Cross Research Ethics Committee) on 19 April 2016: 16/LO/0650.   
Dissemination 
The dissemination of the results from this study will include a short written summary for participants 
(prepared with patient partners), an abstract and poster presentation to be displayed at regional and national 
conferences of orthopaedic health professionals and researchers, and a paper submitted to an international 
orthopaedic journal.  In addition, social media will be used to support publications and presentations with the 
support of research administration at the University of the West of England. 
Study status 
This study commenced on 11 July 2016 on completion of all statutory requirements.   
Discussion 
Many of the orthopaedic community advocate long term follow up but the effect of hip arthroplasty 
surveillance on health related quality of life and health economics at the time of revision hip surgery is 
unknown at present.  It is anticipated that the results of this study will provide information to support the 
design of a larger, multi-centre study which can investigate the use of surveillance following hip arthroplasty. 
Although this is a simple observational study, the burden on patients to complete questionnaires can be 
significant.  The questionnaires in this study have been constructed to minimise this burden and the research 
nurse will be available to assist participants who are in hospital following an emergency admission and may 
require help to compete their questionnaires in order to maximise the response rate.  This group of patients 
are important to the outcome of the study but may be asked to participate in more than one research study; 
consequently, provision has been made to assist them if required. 
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